Nfocus targets new treatment for aneurysms

A mesh-like blob could take over the brain aneurysm world. But first it must win the minds of doctors, regulators and insurers.
Nfocus Neuromedical Inc., the Palo Alto developer of the Luna system for treating brain aneurysms, last month won an important safety tag from European regulators and will ask for clearance from the U.S. Food and Drug Administration in the next six months.